Measures of nebulizer performance – Comparing like with like

R. Hatley, Y. Degtyareva, R. Potter (Chichester, United Kingdom)

Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Session: Novel pharmacological findings in the management of respiratory disorders
Session type: Thematic Poster Session
Number: 715
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Hatley, Y. Degtyareva, R. Potter (Chichester, United Kingdom). Measures of nebulizer performance – Comparing like with like. Eur Respir J 2013; 42: Suppl. 57, 715

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inhaler preference comparing two alternative dual bronchodilator regimens
Source: International Congress 2016 – Pulmonary drug delivery
Year: 2016


Optimizing patient experience of nebulizer treatments
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016

LATE-BREAKING ABSTRACT: Effect of inhalation profiles and throat geometries on predicted lung deposition of budesonide and formoterol (BF) when inhaled through two different devices
Source: International Congress 2014 – Innovative technology and techniques in respiratory function
Year: 2014


The performance of a new vibrating mesh prototype nebulizer for inhaled biodrugs
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014


Optimal adherence with inhaled corticosteroids is related to better health status
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015


Use of an electronic monitoring system to generate objective information on patients’ adherence to taking treatments of a novel inhaled tobramycin solution
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013


Comparison of the in vitro performance of originator and generic drug-combination dry powder inhalers
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013

Delivery of medication by breath-actuated nebulizer (BAN) is similar when used with differing inhalation / exhalation ratios: A contrast to breath enhanced nebulizer (BEN) behavior
Source: International Congress 2014 – Respiratory symptoms in primary care populations
Year: 2014

Extent of inhaled drug deposition at variable inhaler inclination angles and airway geometries: An in-vivo study from a novel computational fluid dynamics model
Source: International Congress 2014 – Asthma and COPD devices and treatments
Year: 2014


Effect of interval between actuations of albuterol HFA inhalers on their aerosol characteristics
Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques
Year: 2016


GLISTEN Study subanalysis: Glycopyrronium differentially improves lung function, health status and rescue medication use when added to salmeterol/fluticasone in COPD severity groups
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015

Preference, satisfaction and critical errors with Genuair® and Breezhaler® in patients with COPD
Source: International Congress 2014 – Asthma and COPD devices and treatments
Year: 2014


Domiciliary nebuliser treatment: How should we assess the response to treatment?
Source: Annual Congress 2003 - Assessing airway function: practicalities and clinical applications
Year: 2003


Tiotropium respimat: Comparison of bronchodilator efficacy of 5 and 2.5 µg doses
Source: International Congress 2014 – Asthma and COPD devices and treatments
Year: 2014


Validation of FEV1 spirometric endpoints as a measure of the anti-inflammatory and bronchodilatory effects of fluticasone/formoterol combination therapy
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013

Real-life asthma impairment: SABA use depends on smoking phenotype
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013


The influence of type of inhalation device on adherence of COPD patients to inhaled medication
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013


Observation of the knowledge and use of inhalers in children
Source: International Congress 2016 – Pulmonary drug delivery
Year: 2016


Mixed treatment analysis comparing tiotropium HandiHaler® and Respimat®
Source: International Congress 2014 – Asthma and COPD devices and treatments
Year: 2014


Abediterol: Efficacy, safety and tolerability of the novel LABA in patients with persistent asthma
Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases
Year: 2014